When tissue is not the only issue: Poorly differentiated lung squamous-cell carcinoma with adrenal, costochondral, and cardiac metastases – case report
暂无分享,去创建一个
O. Aseyev | M. Sadreddini | N. Burute | Megan Clark | Andres G Griborio-Guzman | M. Anthes | Sonja Lubbers
[1] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[2] P. V. Van Schil,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] H. Frick,et al. Multiple primary tumours: challenges and approaches, a review , 2017, ESMO Open.
[4] P. Rosenberg,et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort , 2016, Cancer.
[5] D. Takai,et al. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma , 2016, Expert review of anticancer therapy.
[6] S Senan,et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] C. Bonaïti‐pellié,et al. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] P. McLoone,et al. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study , 2014, BMC Cancer.
[9] R. Zlotecki,et al. Multidisciplinary Management of Soft Tissue Sarcoma , 2013, TheScientificWorldJournal.
[10] Jonathon M. Firnhaber. Diagnosis and treatment of Basal cell and squamous cell carcinoma. , 2012, American family physician.
[11] F. Stella,et al. Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins. , 2012, Interactive cardiovascular and thoracic surgery.
[12] D. Margolis,et al. Delayed treatment and continued growth of nonmelanoma skin cancer. , 2011, Journal of the American Academy of Dermatology.
[13] G. Hospers,et al. Retrospective Denial as A Coping Method , 2011, Journal of Clinical Psychology in Medical Settings.
[14] L. Kemény,et al. Neglected Basal Cell Carcinomas in the 21st Century , 2010, Journal of skin cancer.
[15] D. Malkin. Li-fraumeni syndrome. , 2001, Genes & cancer.
[16] B. Grand,et al. Lung cancer invading the pericardium: quantum of lymph nodes. , 2010, The Annals of thoracic surgery.
[17] J. de Haes,et al. Denial in cancer patients, an explorative review , 2007, Psycho-oncology.
[18] B. Diffey,et al. Skin cancer incidence and the ageing population , 2005, The British journal of dermatology.
[19] S. Markakidis,et al. Large bilateral adrenal metastases in non-small cell lung cancer , 2004, World journal of surgical oncology.
[20] G. Heppner,et al. Tumor heterogeneity: biological implications and therapeutic consequences , 2004, Cancer and Metastasis Reviews.
[21] T. Aburano,et al. Pulmonary Vein and Left Atrial Invasion by Lung Cancer: Assessment by Breath-Hold Gadolinium-Enhanced Three-Dimensional MR Angiography , 2000, Journal of computer assisted tomography.
[22] N. Suzuki,et al. Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. , 1978, Cancer research.
[23] T. Hackett,et al. Development of a quantitative rating scale to assess denial. , 1974, Journal of psychosomatic research.
[24] C. Pasternak,et al. STRUCTURAL ALTERATIONS IN THE SURFACE MEMBRANE DURING THE CELL CYCLE , 1971, The Journal of cell biology.